Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up

Pharmacopsychiatry

Volumn 40, Issue 6, 2007, Pages 264-268

  De Haan, L ^a,b   Van Amelsvoort, T ^a   Dingemans, P ^a   Linszen, D ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; COOPERATION; DISEASE SEVERITY; EXPERIENCE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSTILITY; HUMAN; INTROSPECTION; INVOLUNTARY COMMITMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MENTAL DISEASE; MENTAL PATIENT; MULTIPLE REGRESSION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 36849077335     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992141     Document Type: Article

References (17)

1. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae, Power C. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005; 62: 717-724
2. Fenton WS, Blyer CR, Heinssen RK. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin 1997; 23: 636-651
3. Haan L De, Weisfelt M, Dingemans PMAJ, Linszen DH, Wouters L. Psychometric properties of the subjective well-being under neuroleptics scale (SWN) and the Subjective Deficit Syndrome Scale (SDSS). Psychopharmacology 2002; 162: 24-28
4. Kay SR, Opler LA, Fishbein A. Positive and Negative Syndrome Scale (PANSS) rating manual. Social and Behavioral Sciences Documents, San Rafael, California 1987
5. Keith SJ, Kane JM. Partial compliance and patient consequences in schizophrenia: our patients can do better. J Clin Psychiatry 2003; 64: 1308-1315
6. Kluge M, Wehmeier PM, Dittmann RW, Langer F, Czekalla J, Lehmann M, Kessler FH, Beyenburg S, Naber D. A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-being. Pharmacopsychiatry 2005; 38: 6-12
7. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892-909
8. MacGrath BM, Tempier RP. Patients' opinions of olanzapine and risperidone following long-term treatment: results from a cross-sectional survey. Pharmacopsychiatry 2005; 38: 147-157
9. Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR. Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Arch Gen Psychiatry 1997; 54: 706-712
10. Naber D. A self-rating to measure subjective effects of neuroleptic drugs. Relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clin Psychopharmacol 1994; 12: 133-138
11. Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 2003; 33: 1149-1160
12. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63: 1121-1128
13. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, Green AI, Click IB, Kahn RS, Sharma T, Tohen M, MacEvoy JP, Weiden PJ, Lieberman JA, HGDH Research Group. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006; 83: 53-63
14. Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry 2004; 65: 1211-1218
15. Spitzer RL, Williams JBW. Classification of mental disorders. In Comprehensive Textbook of Psychiatry, 4th edn Edited by Kaplan HJ, Sadock BJ. Baltimore, Williams & Wilkins 1985, 9
16. Tattan TM, Creed FH. Negative symptoms of schizophrenia and compliance with medication. Schizophr Bull 2001; 27: 149-155
17. Weiden P, Rapkin B, Mott T et al. Rating of medication influences (ROMI) Scale in schizophrenia. Schizophrenia Bull 1994; 20: 2